Z Niu1, H Hu, F Tang. 1. Fengyun Tang, Department of neurology, Shaoxing center Hospital, No.1, huayu Road Shaoxing, 312030, China, E-mail: bbyxy804@163.com; Tel: 86- 15857597397.
Abstract
BACKGROUND: The aim of this study is to investigate whether serum and cerebrospinal fluid (CSF) free fatty acid (FFA) levels are associated with outcome and recurrence in a cohort of patients with an acute ischemic stroke (AIS). METHODS: From December 2013 to May 2015, patients with first-ever AIS were included. FFA level and NIH stroke scale (NIHSS) were measured at the time of admission. Logistic regression analysis was used to evaluate the stroke outcome and recurrence according to FFA level. Clinical follow-up was performed at 6 month. RESULTS: In our study, we studied 296 patients (52.7% male). We have found a positive correlation between serum and CSF levels of FFA. Patients with a poor outcome and recurrence had significantly increased FFA serum and CSF levels on admission (all p<0.0001). Multivariate logistic regression analysis adjusted for common risk factors showed that FFA was an independent predictor of poor functional outcome and recurrence. Odds ratios (OR) values were more significant for the higher levels of FFA. CONCLUSION: In summary, baseline serum and CSF FFA level were associated with stroke poor function outcome and recurrence, suggesting an effect of FFA on disease course in AIS.
BACKGROUND: The aim of this study is to investigate whether serum and cerebrospinal fluid (CSF) free fatty acid (FFA) levels are associated with outcome and recurrence in a cohort of patients with an acute ischemic stroke (AIS). METHODS: From December 2013 to May 2015, patients with first-ever AIS were included. FFA level and NIH stroke scale (NIHSS) were measured at the time of admission. Logistic regression analysis was used to evaluate the stroke outcome and recurrence according to FFA level. Clinical follow-up was performed at 6 month. RESULTS: In our study, we studied 296 patients (52.7% male). We have found a positive correlation between serum and CSF levels of FFA. Patients with a poor outcome and recurrence had significantly increased FFA serum and CSF levels on admission (all p<0.0001). Multivariate logistic regression analysis adjusted for common risk factors showed that FFA was an independent predictor of poor functional outcome and recurrence. Odds ratios (OR) values were more significant for the higher levels of FFA. CONCLUSION: In summary, baseline serum and CSF FFA level were associated with stroke poor function outcome and recurrence, suggesting an effect of FFA on disease course in AIS.
Authors: Neeraj Badjatia; David Seres; Amanda Carpenter; J Michael Schmidt; Kiwon Lee; Stephan A Mayer; Jan Claassen; E Sander Connolly; Mitchell S Elkind Journal: Stroke Date: 2012-01-26 Impact factor: 7.914
Authors: Owais Khawaja; Marlena Maziarz; Mary L Biggs; William T Longstreth; Joachim H Ix; Jorge R Kizer; Susan Zieman; Russell P Tracy; Dariush Mozaffarian; Kenneth J Mukamal; David S Siscovick; Luc Djoussé Journal: Int J Stroke Date: 2014-01-21 Impact factor: 5.266
Authors: Owais Khawaja; Traci M Bartz; Joachim H Ix; Susan R Heckbert; Jorge R Kizer; Susan J Zieman; Kenneth J Mukamal; Russell P Tracy; David S Siscovick; Luc Djoussé Journal: Am J Cardiol Date: 2012-04-12 Impact factor: 2.778
Authors: Lutz P Breitling; Dietrich Rothenbacher; Norma C Grandi; Winfried März; Hermann Brenner Journal: Am J Cardiol Date: 2011-05-31 Impact factor: 2.778
Authors: J G Pilitsis; W M Coplin; M H O'Regan; J M Wellwood; F G Diaz; M R Fairfax; D B Michael; J W Phillis Journal: Brain Res Date: 2003-09-26 Impact factor: 3.252
Authors: Sirin Yaemsiri; Souvik Sen; Lesley F Tinker; Whitney R Robinson; Rhobert W Evans; Wayne Rosamond; Sylvia Wasserthiel-Smoller; Ka He Journal: Stroke Date: 2013-07-30 Impact factor: 7.914